Get the Stockscreener App
449.36
4.15%
17.92
After Hours:
449.96
0.60
+0.13%
Tesla Inc stock is traded at $449.36, with a volume of 70.88M.
It is up +4.15% in the last 24 hours and down -8.06% over the past month.
Tesla is a vertically integrated battery electric vehicle automaker and developer of real world artificial intelligence software, which includes autonomous driving and humanoid robots. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling a sports car and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network and an auto insurance business.
See More
Previous Close:
$431.44
Open:
$435.16
24h Volume:
70.88M
Relative Volume:
0.93
Market Cap:
$1.49T
Revenue:
$95.63B
Net Income/Loss:
$5.33B
P/E Ratio:
300.25
EPS:
1.4966
Net Cash Flow:
$6.83B
1W Performance:
+2.46%
1M Performance:
-8.06%
6M Performance:
+35.30%
1Y Performance:
+8.25%
1-Day Range:
$432.63
$449.50
1-Week Range:
$417.44
$449.50
52-Week Range:
$214.25
$498.83
Tesla Inc Stock (TSLA) Company Profile
Name
Tesla Inc
Sector
Industry
Phone
512-516-8177
Address
1 TESLA ROAD, AUSTIN, CA
Compare TSLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TSLA
Tesla Inc
|
449.36 | 1.43T | 95.63B | 5.33B | 6.83B | 1.4966 |
|
TM
Toyota Motor Corporation Adr
|
227.04 | 296.82B | 331.17B | 31.82B | -71.95M | 23.65 |
|
GM
General Motors Company
|
81.14 | 75.50B | 187.44B | 3.17B | -1.75B | 4.9755 |
|
RACE
Ferrari N V
|
337.55 | 60.54B | 7.83B | 1.77B | 1.54B | 9.9015 |
|
F
Ford Motor Co
|
13.71 | 54.87B | 189.59B | 4.72B | 11.90B | 1.1662 |
Tesla Inc Stock (TSLA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Reiterated | Wells Fargo | Underweight |
| Jan-02-26 | Reiterated | Truist | Hold |
| Dec-08-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-29-25 | Reiterated | BofA Securities | Neutral |
| Oct-23-25 | Reiterated | Canaccord Genuity | Buy |
| Oct-23-25 | Reiterated | Deutsche Bank | Buy |
| Oct-23-25 | Reiterated | Mizuho | Outperform |
| Oct-23-25 | Reiterated | Truist | Hold |
| Oct-16-25 | Initiated | BNP Paribas Exane | Underperform |
| Oct-16-25 | Reiterated | Barclays | Equal Weight |
| Oct-13-25 | Initiated | Melius | Buy |
| Oct-10-25 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-09-25 | Reiterated | TD Cowen | Buy |
| Oct-08-25 | Reiterated | Stifel | Buy |
| Sep-30-25 | Reiterated | Canaccord Genuity | Buy |
| Sep-26-25 | Reiterated | Deutsche Bank | Buy |
| Sep-23-25 | Reiterated | Mizuho | Outperform |
| Sep-22-25 | Reiterated | Piper Sandler | Overweight |
| Sep-19-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-18-25 | Reiterated | Goldman | Neutral |
| Jul-29-25 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-25-25 | Downgrade | China Renaissance | Buy → Hold |
| Jul-24-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-26-25 | Reiterated | The Benchmark Company | Buy |
| Jun-09-25 | Downgrade | Argus | Buy → Hold |
| Jun-09-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-21-25 | Reiterated | Barclays | Equal Weight |
| Apr-16-25 | Reiterated | Piper Sandler | Overweight |
| Apr-09-25 | Reiterated | The Benchmark Company | Buy |
| Apr-07-25 | Reiterated | Wedbush | Outperform |
| Mar-31-25 | Reiterated | Stifel | Buy |
| Mar-28-25 | Reiterated | Deutsche Bank | Buy |
| Mar-27-25 | Reiterated | HSBC Securities | Reduce |
| Mar-20-25 | Reiterated | Piper Sandler | Overweight |
| Mar-19-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-18-25 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-14-25 | Reiterated | Wells Fargo | Underweight |
| Mar-12-25 | Reiterated | Guggenheim | Sell |
| Mar-10-25 | Reiterated | UBS | Sell |
| Mar-07-25 | Upgrade | TD Cowen | Hold → Buy |
| Feb-12-25 | Initiated | The Benchmark Company | Buy |
| Jan-22-25 | Reiterated | Wedbush | Outperform |
| Jan-15-25 | Reiterated | Barclays | Equal Weight |
| Jan-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-06-25 | Upgrade | New Street | Neutral → Buy |
| Dec-18-24 | Reiterated | Robert W. Baird | Outperform |
| Dec-17-24 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-24 | Upgrade | ROTH MKM | Neutral → Buy |
| Oct-24-24 | Reiterated | Canaccord Genuity | Buy |
| Oct-24-24 | Reiterated | Cantor Fitzgerald | Neutral |
| Oct-24-24 | Reiterated | Goldman | Neutral |
| Oct-24-24 | Reiterated | Jefferies | Hold |
| Oct-24-24 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Reiterated | Truist | Hold |
| Oct-24-24 | Reiterated | Wells Fargo | Underweight |
| Sep-25-24 | Reiterated | Piper Sandler | Overweight |
| Sep-10-24 | Resumed | Deutsche Bank | Buy |
| Sep-05-24 | Resumed | Wolfe Research | Peer Perform |
| Aug-29-24 | Initiated | William Blair | Outperform |
| Jul-24-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-24-24 | Reiterated | Citigroup | Neutral |
| Jul-24-24 | Reiterated | Goldman | Neutral |
| Jul-24-24 | Downgrade | New Street | Buy → Neutral |
| Jul-24-24 | Reiterated | Piper Sandler | Overweight |
| Jul-24-24 | Reiterated | Truist | Hold |
| Jul-17-24 | Reiterated | Barclays | Equal Weight |
| Jul-12-24 | Reiterated | Mizuho | Neutral |
| Jul-12-24 | Downgrade | UBS | Neutral → Sell |
| Jul-10-24 | Reiterated | Goldman | Neutral |
| Jul-05-24 | Upgrade | China Renaissance | Hold → Buy |
| Jul-03-24 | Reiterated | Guggenheim | Sell |
| Jul-03-24 | Reiterated | Wedbush | Outperform |
| Jun-26-24 | Initiated | Stifel | Buy |
| Jun-12-24 | Reiterated | Citigroup | Neutral |
| May-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-24-24 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-24 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-18-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Apr-17-24 | Reiterated | Barclays | Equal Weight |
| Apr-12-24 | Reiterated | Citigroup | Neutral |
| Apr-12-24 | Reiterated | Wells Fargo | Underweight |
| Apr-10-24 | Reiterated | Piper Sandler | Overweight |
| Apr-04-24 | Reiterated | Morgan Stanley | Overweight |
| Apr-03-24 | Reiterated | Deutsche Bank | Buy |
| Apr-03-24 | Reiterated | HSBC Securities | Reduce |
| Apr-03-24 | Reiterated | JP Morgan | Underweight |
| Apr-03-24 | Reiterated | Robert W. Baird | Outperform |
| Apr-03-24 | Reiterated | Truist | Hold |
| Mar-28-24 | Reiterated | Deutsche Bank | Buy |
| Mar-28-24 | Reiterated | Wedbush | Outperform |
| Mar-27-24 | Reiterated | Citigroup | Neutral |
| Mar-25-24 | Downgrade | Mizuho | Buy → Neutral |
| Mar-18-24 | Reiterated | Goldman | Neutral |
| Mar-13-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Feb-26-24 | Initiated | China Renaissance | Hold |
| Feb-06-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jan-29-24 | Reiterated | Jefferies | Hold |
| Jan-26-24 | Downgrade | Edward Jones | Buy → Hold |
| Jan-25-24 | Reiterated | Barclays | Equal Weight |
| Jan-25-24 | Reiterated | Canaccord Genuity | Buy |
| Jan-25-24 | Reiterated | Citigroup | Neutral |
| Jan-25-24 | Reiterated | Goldman | Neutral |
| Jan-25-24 | Reiterated | Mizuho | Buy |
| Jan-25-24 | Reiterated | TD Cowen | Market Perform |
| Jan-25-24 | Reiterated | UBS | Neutral |
| Jan-25-24 | Reiterated | Wells Fargo | Equal Weight |
| Jan-24-24 | Initiated | Redburn Atlantic | Sell |
| Jan-18-24 | Reiterated | Barclays | Equal Weight |
| Jan-17-24 | Reiterated | Wells Fargo | Equal Weight |
| Nov-09-23 | Initiated | HSBC Securities | Reduce |
| Sep-27-23 | Reiterated | Deutsche Bank | Buy |
| Sep-13-23 | Initiated | UBS | Neutral |
| Sep-11-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-24-23 | Downgrade | UBS | Buy → Neutral |
| Jul-17-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-17-23 | Reiterated | Wells Fargo | Equal Weight |
| Jul-12-23 | Reiterated | Citigroup | Neutral |
| Jul-10-23 | Reiterated | Jefferies | Hold |
| Jul-03-23 | Reiterated | Canaccord Genuity | Buy |
| Jul-03-23 | Reiterated | Deutsche Bank | Buy |
| Jul-03-23 | Reiterated | Goldman | Neutral |
| Jul-03-23 | Reiterated | JP Morgan | Underweight |
| Jul-03-23 | Reiterated | Truist | Hold |
| Jun-26-23 | Downgrade | Goldman | Buy → Neutral |
| Jun-23-23 | Downgrade | DZ Bank | Buy → Sell |
| Jun-22-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-21-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-26-23 | Downgrade | Jefferies | Buy → Hold |
| Apr-24-23 | Reiterated | Daiwa Securities | Outperform |
| Apr-21-23 | Downgrade | Truist | Buy → Hold |
| Apr-20-23 | Reiterated | BofA Securities | Neutral |
| Apr-20-23 | Reiterated | Canaccord Genuity | Buy |
| Apr-20-23 | Reiterated | Citigroup | Neutral |
| Apr-20-23 | Reiterated | Deutsche Bank | Buy |
| Apr-20-23 | Reiterated | Goldman | Buy |
| Apr-20-23 | Reiterated | JP Morgan | Underweight |
| Apr-20-23 | Reiterated | Mizuho | Buy |
| Apr-20-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-20-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-20-23 | Downgrade | Tudor, Pickering, Holt & Co. | Hold → Sell |
| Apr-20-23 | Reiterated | Wells Fargo | Equal Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-03-23 | Reiterated | Goldman | Buy |
| Apr-03-23 | Reiterated | TD Cowen | Market Perform |
| Mar-27-23 | Reiterated | Citigroup | Neutral |
| Mar-13-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-08-23 | Downgrade | Berenberg | Buy → Hold |
| Feb-15-23 | Initiated | Barclays | Overweight |
| Jan-30-23 | Upgrade | Berenberg | Hold → Buy |
| Jan-27-23 | Reiterated | Argus | Buy |
| Jan-23-23 | Reiterated | Truist | Buy |
| Jan-13-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-09-23 | Reiterated | BofA Securities | Neutral |
| Jan-05-23 | Upgrade | Edward Jones | Hold → Buy |
| Jan-03-23 | Reiterated | Goldman | Buy |
| Jan-03-23 | Reiterated | JP Morgan | Underweight |
| Jan-03-23 | Reiterated | Truist | Buy |
| Dec-29-22 | Reiterated | Morgan Stanley | Overweight |
| Dec-28-22 | Reiterated | Robert W. Baird | Outperform |
| Dec-23-22 | Reiterated | Wedbush | Outperform |
| Dec-22-22 | Reiterated | Canaccord Genuity | Buy |
| Dec-19-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-23-22 | Upgrade | Citigroup | Sell → Neutral |
| Oct-20-22 | Reiterated | Wedbush | Outperform |
| Oct-20-22 | Reiterated | Wolfe Research | Outperform |
| Jul-14-22 | Initiated | Truist | Buy |
| Jul-13-22 | Resumed | Canaccord Genuity | Buy |
| Jun-24-22 | Reiterated | Credit Suisse | Outperform |
| Jun-13-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-09-22 | Upgrade | UBS | Neutral → Buy |
| May-17-22 | Upgrade | Tudor, Pickering, Holt & Co. | Sell → Hold |
| May-10-22 | Initiated | Berenberg | Hold |
| Feb-25-22 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-31-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-27-22 | Reiterated | Citigroup | Sell |
| Jan-27-22 | Reiterated | Cowen | Market Perform |
| Jan-27-22 | Reiterated | JP Morgan | Underweight |
| Jan-27-22 | Reiterated | Oppenheimer | Outperform |
| Jan-27-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-27-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Reiterated | Barclays | Underweight |
| Jan-03-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Dec-30-21 | Reiterated | Citigroup | Sell |
| Dec-20-21 | Initiated | Guggenheim | Neutral |
| Dec-07-21 | Reiterated | UBS | Neutral |
| Nov-08-21 | Reiterated | Jefferies | Buy |
| Oct-25-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-21-21 | Reiterated | BofA Securities | Neutral |
| Oct-21-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-21-21 | Reiterated | Cowen | Market Perform |
| Oct-21-21 | Reiterated | Credit Suisse | Neutral |
| Oct-21-21 | Reiterated | Deutsche Bank | Buy |
| Oct-21-21 | Reiterated | Mizuho | Buy |
| Oct-21-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-21-21 | Reiterated | Robert W. Baird | Outperform |
| Oct-21-21 | Reiterated | Wedbush | Outperform |
| Oct-21-21 | Reiterated | Wells Fargo | Equal Weight |
| Oct-08-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-23-21 | Initiated | Tudor Pickering | Sell |
| Sep-23-21 | Initiated | Tudor, Pickering, Holt & Co. | Sell |
| Aug-17-21 | Reiterated | Bernstein | Underperform |
| Aug-12-21 | Reiterated | UBS | Neutral |
| Aug-09-21 | Upgrade | Jefferies | Hold → Buy |
| Aug-03-21 | Reiterated | Piper Sandler | Overweight |
| Jul-29-21 | Upgrade | DZ Bank | Sell → Buy |
| Jun-29-21 | Reiterated | UBS | Neutral |
| Jun-14-21 | Reiterated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Wells Fargo | Equal Weight |
| Apr-27-21 | Reiterated | Canaccord Genuity | Buy |
| Apr-20-21 | Reiterated | Mizuho | Buy |
| Apr-12-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Apr-05-21 | Upgrade | Wedbush | Neutral → Outperform |
| Mar-11-21 | Initiated | Mizuho | Buy |
| Mar-09-21 | Upgrade | New Street | Neutral → Buy |
| Mar-03-21 | Reiterated | UBS | Neutral |
| Feb-01-21 | Reiterated | Piper Sandler | Overweight |
| Jan-28-21 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-25-21 | Reiterated | Robert W. Baird | Outperform |
| Jan-20-21 | Reiterated | Oppenheimer | Outperform |
| Jan-19-21 | Reiterated | Jefferies | Hold |
| Jan-15-21 | Reiterated | Wedbush | Neutral |
| Jan-13-21 | Initiated | Edward Jones | Hold |
| Jan-11-21 | Reiterated | BofA Securities | Neutral |
| Jan-08-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Jan-07-21 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Jan-06-21 | Reiterated | Morgan Stanley | Overweight |
| Jan-05-21 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| Dec-11-20 | Downgrade | Jefferies | Buy → Hold |
| Dec-10-20 | Downgrade | New Street | Buy → Neutral |
| Dec-03-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-30-20 | Upgrade | CFRA | Buy → Strong Buy |
| Oct-23-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Oct-22-20 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Oct-22-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-16-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Oct-08-20 | Upgrade | New Street | Neutral → Buy |
| Sep-23-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-20 | Reiterated | Robert W. Baird | Neutral |
| Sep-18-20 | Reiterated | Piper Sandler | Overweight |
| Sep-16-20 | Reiterated | Credit Suisse | Neutral |
| Sep-11-20 | Reiterated | UBS | Neutral |
| Sep-04-20 | Upgrade | CFRA | Sell → Buy |
| Aug-26-20 | Reiterated | Jefferies | Buy |
| Aug-14-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-14-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
View All
Tesla Inc Stock (TSLA) Latest News
New York court acquits Tesla: faulty screen not the cause of accident - Українські Національні Новини
Tesla (TSLA) Price Forecast: Pullback Sets Stage for Next Breakout - FXEmpire
Elon Musk says Tesla will likely sell humanoid robots by end of next year - Fox Business
SpaceX IPO Tops Question List For Tesla's Q4 Conference Call: Will Shareholders Get First Access? - Benzinga
Tesla Inc (TSLA) Triggers Power Inflow Signal, Stock Rises to $449.12 - Intellectia AI
Tesla (NASDAQ:TSLA) Trading 4.2% Higher on Analyst Upgrade - MarketBeat
Tesla prepares to launch FSD autopilot in Europe and China as early as February - Українські Національні Новини
Tesla lost the most share last year in EV-stronghold California - mercurynews.com
Tesla Shares Rise Over 3% Following Key Trading Signal - Benzinga
Tesla stock pops as Elon Musk posts video claiming no safety monitor in Austin robotaxi - Yahoo Finance
Tesla Loses Most Market Share in California EV Market in 2025 - Transport Topics
Tesla finally launches robotaxi rides without safety monitors, years after CEO Elon Musk’s 2020 target - Automotive News
Tesla testing robotaxis without a human safety monitor - Yahoo Finance
Motion to Compel Arbitration Was Improperly Denied - The National Law Review
Tesla: Clear Skies In 2026, But A Storm Could Cut Valuation In 2027 (NASDAQ:TSLA) - Seeking Alpha
Elon Musk Says Optimus Robots Are Coming Your Way. That Has Tesla Stock on the Rise. - Investopedia
Tesla Launches Robotaxi Service in Austin Without Safety Monitors - Intellectia AI
Tesla’s Fully Autonomous Robotaxi Is Finally Here — Musk Now Wants New Talent To Launch Humanoid Robots - Stocktwits
Is the Market Bullish or Bearish on Tesla Inc? - Benzinga
Tesla Robotaxi Rides Without Safety Drivers Start in Austin - Transport Topics
Musk says Tesla's Optimus robots could go on sale by the end of 2027 - Yahoo Finance
Lemonade's Tesla Deal Could Rewrite How Auto Insurance Is Priced - Finviz
Tesla Needs 20M FSD Subscribers Annually To Justify Its Valuation (NASDAQ: TSLA) - Seeking Alpha
Tesla Launches Robotaxi Rides Without a Human Chaperone in Austin - Business Insider
Elon Musk: Tesla Optimus Robots for Sale by 2027, May Outnumber Humans - WebProNews
Dear Tesla Stock Fans, Mark Your Calendars for January 28 - Barchart.com
Tesla’s stock pops on a robotaxi milestone. Here’s what comes next. - MarketWatch
Tesla Starts Public Robotaxi Rides in Austin With Ex-Employee - Bloomberg.com
Lemonade’s Tesla Deal Could Rewrite How Auto Insurance Is Priced - MarketBeat
Tesla Launches Unsupervised Robotaxi Rides in Austin, Texas, CEO Musk Says - marketscreener.com
Tesla, BYD Production Could Be Hit By DRAM Chip Shortage, Report Says - Investor's Business Daily
Tesla Lost the Most Share Last Year in EV-Stronghold California - Bloomberg.com
Tesla launches robotaxi rides in Austin with no human safety driver - Yahoo! Autos
Elon Musk says Tesla Robotaxis are operating without drivers, sending stock higher - Sherwood News
Here is why Tesla could be a beneficiary of a new tariff deal between China and Canada - MSN
TSLA: Tesla Stock Rises as Musk Flags Cybercab Progress - GuruFocus
Musk: Robotaxis in Austin now without safety monitor - breakingthenews.net
Tesla Envisioned to Begin Public Sales of Optimus Humanoid Robots by End of Next Year - AASTOCKS.com
Elon Musk has an ambitious new target for when Tesla’s Optimus robots will go on sale - MarketWatch
Tesla starts robotaxi rides without safety monitors in Austin - Reuters
Lemonade’s Tesla insurance product validates FSD technology, Morgan Stanley notes - Investing.com
Musk: Just started Tesla Robotaxi drives in Austin with no safety monitor in car - marketscreener.com
Elon Musk: Tesla will sell humanoid robots by end of 2027 - Axios
Tesla Aims for Widespread Robotaxi Service in U.S. by End of 2026 - Intellectia AI
Davos-Musk expects Europe, China to approve Tesla's FSD system next month - Reuters
Lemonade Launches Autonomous Vehicle Insurance With 50% Rate Reduction for Tesla FSD - CollisionWeek
Lemonade and Tesla Collaborate: Innovative Car Insurance Shakes Industry - StocksToTrade
Elon Musk: Tesla robotaxi will be 'widespread' in US before 2027 - Yahoo Finance
Tesla to Sell Optimus Robots to Public Next Year, Musk Says - Bloomberg.com
Tesla registrations in California declined 11.4% in 2025CNCDA report - marketscreener.com
Musk expects Europe, China to approve Tesla's FSD system next month - Yahoo! Finance Canada
Tesla Inc Stock (TSLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.31%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):